Details for New Drug Application (NDA): 013790
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
NDA 013790 describes CORDRAN, which is a drug marketed by Almirall and Lilly and is included in five NDAs. It is available from two suppliers. Additional details are available on the CORDRAN profile page.
The generic ingredient in CORDRAN is flurandrenolide; neomycin sulfate. There are four drug master file entries for this compound. Additional details are available on the flurandrenolide; neomycin sulfate profile page.
The generic ingredient in CORDRAN is flurandrenolide; neomycin sulfate. There are four drug master file entries for this compound. Additional details are available on the flurandrenolide; neomycin sulfate profile page.
Summary for 013790
| Tradename: | CORDRAN |
| Applicant: | Almirall |
| Ingredient: | flurandrenolide |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 013790
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 013790
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CORDRAN | flurandrenolide | LOTION;TOPICAL | 013790 | NDA | Almirall, LLC | 16110-052 | 16110-052-12 | 120 mL in 1 BOTTLE, PLASTIC (16110-052-12) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | LOTION;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AT | RLD: | Yes | ||||
Complete Access Available with Subscription
